Skip to main
Gurl Peptide

Melanocortin and reproductive-axis peptides studied for libido, arousal and the reproductive hormone axis.

DESIRE & AROUSAL RESEARCH / COLOPHON

About This Reference Desk

A citation-anchored reading of the desire-and-arousal peptide literature. Not a vendor. Not a clinic. Not medical advice.

What Gurl Peptide is

Gurl Peptide reads the published research on three peptides that surface again and again in talk about sexual desire, arousal and the reproductive hormone axis: PT-141 (the lead), Kisspeptin and Melanotan II. Much of what circulates about them is scattered, thinly sourced, or plain overstated; the job here is to lay each one out plainly and show, with citations, exactly what it was tested for, in which species, and how far that evidence actually carries.

The three reach libido and reproductive signaling by different routes — the central melanocortin desire circuits (PT-141), the upstream GnRH axis (Kisspeptin), and broad non-selective melanocortin activity (Melanotan II) — so reading them alongside one another gives a truer picture than any single compound taken alone. Each has a page of its own; a side-by-side comparison sets them against each other; and one shared reference list gathers every source. The register is deliberately spare — short, declarative sentences — and the record is given at its real strength, including where it is weak, contested, or shadowed by serious safety cautions.

How it is compiled

Three habits shape every page.

The literature comes first. Each research claim carries a numbered citation — PubMed-indexed papers, trial reports, regulatory records and systematic reviews — gathered on the references page. A finding drawn from a review is marked as coming from a review, and the numbering stays fixed across the site.

Evidence is given at face value, no more. A dose is stated in the species and route it was actually tested in — say, 0.025 mg/kg subcutaneously in men with psychogenic erectile dysfunction — and is never rescaled to a person or dressed up as a suggestion. Where the basis is a single small study, or Phase 1/2 work, or animals only, the page says so; where a case report documents a hazard, it is shown rather than tucked away.

The pages talk to each other. Because these compounds share lineage and mechanism, each page links to the others, so a reader can trace how one thread — central MC4R desire signaling, for instance — runs from Melanotan II through to PT-141.

What it is not

This is a reading desk, not a store, a clinic, or a source of medical or sexual-health advice. It sells, supplies, sources and brokers nothing, and it has no affiliate or referral relationship with any vendor. No clinician works here; it diagnoses no condition and prescribes nothing. It recommends no dose, schedule or route for any person, and it never frames an animal-study or clinical-trial dose as something an individual should take.

The peptides discussed here are research compounds. PT-141 has an FDA-approved pharmaceutical form for a narrow indication, but research-grade PT-141 sold online is outside that framework. Kisspeptin is fully investigational. Melanotan II is unapproved and carries serious documented cautions. Readers interested in any condition described in the underlying research should consult a licensed clinician operating within their own jurisdiction. The value here is a calm, accurate map of the literature — nothing more, and nothing it pretends to be.